Characteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate-to-severe plaque psoriasis - nationwide results from the DERMBIO registry-Reference-Cited by-同舟云学术

Characteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate-to-severe plaque psoriasis - nationwide results from the DERMBIO registry

Published:2017-03-29 Issue:7 Volume:31 Page:1183-1187
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Egeberg A.¹,Iversen L.²,Gniadecki R.³,Hvid L.⁴,Dam T.N.⁵,Bryld L.E.⁶,Skov L.¹

Affiliation:

1. Department of Dermatology and Allergy; Herlev and Gentofte Hospital; University of Copenhagen; Hellerup Denmark

2. Department of Dermatology; Aarhus University Hospital; Aarhus Denmark

3. Department of Dermatology; Bispebjerg Hospital; Copenhagen Denmark

4. Department of Dermatology and Allergy Centre; Odense University Hospital; Odense Denmark

5. Skin Clinic; Nykøbing Falster Denmark

6. Department of Dermatology; Roskilde Hospital; Roskilde Denmark

Funder

Pfizer

Eli Lilly and Company

AbbVie

Novartis

Amgen

Celgene

Centocor

Janssen-Cilag

Leo Pharma

Merck Sharp and Dohme

Universidade Católica de Brasília

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.14200/fullpdf

Reference15 articles.

1. Global epidemiology of psoriasis: a systematic review of incidence and prevalence;Parisi;J Invest Dermatol,2013

2. The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men;Hagg;PLoS One,2013

3. Role of IL-17 in psoriasis and psoriatic arthritis;Raychaudhuri;Clin Rev Allergy Immunol,2013

4. Psoriasis;Boehncke;Lancet,2015

5. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics;Mease;J Am Acad Dermatol,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide Study;Acta Dermato-Venereologica;2023-11-21

2. Disease‐ and treatment‐related expectations, attitudes, and beliefs among adult patients initiating or switching biological therapies for psoriasis;JEADV Clinical Practice;2023-09-13

3. Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study;Journal of the American Academy of Dermatology;2023-06

4. Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials;British Journal of Dermatology;2022-10-21

5. Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual Level;JAMA Dermatology;2022-10-01